Christopher Richard Cote

Christopher Cote practices at Associates Of Otolaryngology in Denver, Colorado.

Christopher Cote's NPI, 1700880085, was assigned on June 2, 2005. Christopher Cote graduated from Tufts University School Of Medicine in 1997. Christopher Cote holds Colorado license 48236.

Christopher Cote's primary practice is Associates of Otolaryngology, at 850 E Harvard Ave Suite 505 Suite 505, Denver, CO 80210-5078. The practice phone is (303) 744-1961.

Christopher Cote's primary practice is Associates Of Otolaryngology in Denver, Colorado. The medical group on file is AOO | ENT Specialists of the Rockies.

Dmand AI tracks the electronic health record (EHR) system at each site where Christopher Cote practices. Vendor and product names are available with a free account.

Otolaryngology/facial plastic surgery is Christopher Cote's primary specialty in the NPI Registry, under taxonomy code 207YX0905X. Christopher Cote is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Christopher Cote's licenses on file in 3 states: Colorado, Virginia and Maryland.

Dmand AI lists acute sinusitis, chronic nasal allergies, ear eustachian tube disorders, endoscopic sinus surgery, hearing loss and impairment, larynx and vocal cord disease and tinnitus among the conditions Christopher Cote treats.

CMS data shows 864 Medicare services from Christopher Cote across 12 procedure codes in 2024, for 195 Medicare patients. Medicare paid $35,321 for them. Every service was in an office.

CMS counts 195 Medicare patients who saw Christopher Cote in 2024. The largest group is 65 to 74, with 103 patients. 75% of them have high cholesterol, and 55% have high blood pressure. Their average risk score is 1.04, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Christopher Cote's median patient age at 50, with 56% women.

In 2024, Christopher Cote wrote 424 Medicare Part D claims for 152 patients. 98% of them were for generic drugs. CMS names the drug for 341 of them, across 9 drugs with 11 or more claims each, at $4,981 in total drug cost. In 2023, CMS named 234 claims across 6 drugs.

Christopher Cote accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links Christopher Cote to 1 clinical trial. Conditions studied include Endolymphatic Hydrops and Meniere Disease. Open Payments lists research payments to Christopher Cote that name 1 trial.

CMS Open Payments shows 79 general payments to Christopher Cote from 20 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Allergan Inc. paid the most, $570. It also lists 1 research payment totaling $16 in 2020, naming 1 clinical trial.

Dmand AI lists 3 awards for Christopher Cote, most recently CMS Stage 1 EHR in 2014.

Christopher Cote graduated from Tufts University School Of Medicine in 1997. Christopher Cote is a member of NHS.

Christopher Cote is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.